Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Onset of Parkinson's Disease Identified Through Hyperhidrosis: A Middle-Aged Woman Case Report.

Reports (MDPI)·2026
Same author

Exploring heterogeneity in antibiotic choices for bloodstream infections caused by AmpC-producing enterobacterales: results from a case-vignette study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort.

The Journal of antimicrobial chemotherapy·2025
Same author

Streptococcus pneumoniae bacteremia: comparison of incidence, epidemiology, and clinical outcome in a pre- and post-COVID-19 period.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

Prevalence and risk factors of cognitive frailty in people with HIV.

AIDS (London, England)·2025
Same author

Update on infection prevention in the ICU.

Current opinion in critical care·2025

相关实验视频

Updated: Jul 6, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

在常规临床实践中使用两种商业血液测试来诊断感染Mycobacterium结核病:一项前性研究.

Giovanni Ferrara1, Monica Losi, Roberto D'Amico

  • 1Section of Respiratory Disease, Department of Oncology, Haematology, and Respiratory Disease, University of Modena and Reggio Emilia, Via del Pozzo, 71-41100 Modena, Italy.

Lancet (London, England)
|April 25, 2006
PubMed
概括

与皮肤测试相比,T-SPOT.TB和QuantiFERON-TB金色测试对潜在结核病感染的诊断具有更高的特异性. 然而,不同的不确定和阳性结果率表明这些血液测试具有明显的临床实用性.

更多相关视频

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

相关实验视频

Last Updated: Jul 6, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

科学领域:

  • 传染性疾病 传染性疾病
  • 免疫学 免疫学 免疫学
  • 诊断医学 诊断医学

背景情况:

  • 潜在结核病感染 (LTBI) 诊断依赖于结核素皮肤测试 (TST) 和干扰素释测试 (IGRA).
  • T-SPOT.TB 和 QuantiFERON-TB Gold 是用于LTBI诊断的商业IGRA.
  • 以前的研究将每个IGRA单独与TST进行了比较.

研究的目的:

  • 在同一患者群体内直接比较T-SPOT.TB,QuantiFERON-TB Gold和TST的诊断疗效.
  • 评估测试性能的差异,包括不确定性/阳性结果的特异性和率.

主要方法:

  • 对393名怀疑结核病的患者进行前性研究.
  • 同时使用T-SPOT.TB和QuantiFERON-TB Gold进行测试.
  • 结核素皮肤测试 (TST) 结果可用于318名患者.

主要成果:

  • 无论是T-SPOT.TB还是QuantiFERON-TB Gold都显示出比TST更高的特异性,特别是在BCG接种疫苗的个体中.
  • 与T-SPOT.TB (3%) 相比,QuantiFERON-TB Gold的不确定性结果 (11%) 显著更多.
  • T-SPOT.TB 总体上 (38%对26%) 和在活跃结核病病例的密切接触者中产生了更多的积极结果.

结论:

  • T-SPOT.TB和QuantiFERON-TB Gold为LTBI诊断提供了比TST更好的特异性.
  • 不确定和阳性结果率的差异表明,T-SPOT.TB和QuantiFERON-TB Gold在临床实践中可能无法互换.
  • 需要进一步的研究,以澄清不同患者群体中每种血液检测的最佳使用情况.